Post-renal transplantation hypophosphatemia
- 15 July 2009
- journal article
- review article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 25 (2) , 213-220
Abstract
An understanding of the pathophysiologic mechanisms of post-renal transplant (PRT) bone disease is of important clinical significance. Although bone disease occurs after all solid organ transplantation, the cumulative skeletal fracture rate remains high in PRT subjects while reaching a plateau with other transplantations. One major difference in the pathophysiology of PRT bone disease is, perhaps, due to persistent renal phosphorus (Pi) wasting. Novel phosphaturic agents have recently been suggested to participate in the development of bone disease in PRT subjects. However, it is unclear as of yet whether these factors alone or in conjunction with excess parathyroid hormone (PTH) secretion play a key role in the development of negative Pi balance and consequent bone disease in this population. In this review, I present a natural history of PRT hypophosphatemia and persistent renal Pi leak, provide pathophysiologic insight into these developments, and discuss the difficulty in diagnosing these phenotypes in both adult and pediatric populations.Keywords
This publication has 83 references indexed in Scilit:
- Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Bone Mineralization in Children with Renal Failure on Peritoneal DialysisThe Journal of Clinical Endocrinology & Metabolism, 2009
- FGFR3 and FGFR4 Do not Mediate Renal Effects of FGF23Journal of the American Society of Nephrology, 2008
- Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In VitroJournal of Bone and Mineral Research, 2008
- Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Klotho converts canonical FGF receptor into a specific receptor for FGF23Nature, 2006
- Post-renal transplantation hypophosphatemia: a review and novel insightsCurrent Opinion in Nephrology and Hypertension, 2006
- FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate HomeostasisJournal of Bone and Mineral Research, 2004
- Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturiaKidney International, 2001
- OKT3 monoclonal antibody reversal of renal and hepatic rejection in pediatric patientsThe Journal of Pediatrics, 1987
- Decreased phosphate reabsorption after renal transplantation: Evidence for a mechanism independent of calcium and parathyroid hormoneKidney International, 1981